2003
DOI: 10.1111/j.1540-9740.2003.03113.x
|View full text |Cite
|
Sign up to set email alerts
|

Delusions of Parasitiosis: a Case With a Review of its Course and Treatment

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2007
2007
2012
2012

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 6 publications
0
4
0
Order By: Relevance
“…To our knowledge, this is the first complete collection of patients with primary delusional parasitosis treated with atypical antipsychotics, whereas many patients with secondary forms of delusional parasitosis have been reported in recent years (e.g. De Leon et al , 1997; Safer et al , 1997; Kumbier & Kornhuber, 2002; Freudenmann, 2003; Le & Gonski, 2003; Scheinfeld, 2003; Wenning et al , 2003). Thus the evidence for the use of atypical antipsychotics in delusional parasitosis is even weaker than for typical antipsychotics.…”
Section: Discussionmentioning
confidence: 99%
“…To our knowledge, this is the first complete collection of patients with primary delusional parasitosis treated with atypical antipsychotics, whereas many patients with secondary forms of delusional parasitosis have been reported in recent years (e.g. De Leon et al , 1997; Safer et al , 1997; Kumbier & Kornhuber, 2002; Freudenmann, 2003; Le & Gonski, 2003; Scheinfeld, 2003; Wenning et al , 2003). Thus the evidence for the use of atypical antipsychotics in delusional parasitosis is even weaker than for typical antipsychotics.…”
Section: Discussionmentioning
confidence: 99%
“…In a 72-year-old male with a 5-year history of primary DI which failed to respond to haloperidol decanoate, symptoms started to abate after only 1 week of oral risperidone therapy. Meanwhile, there are well over 30 published cases with risperidone for all forms of DI (3,53,57,68,102,103,141,155,168,172,197,212,213,225,243,244,249,254,258,278,282,341). Since the mid-1990s, further atypical antipsychotics have been licensed for the treatment of schizophrenia, and all of these substances have since been used, with various effects, in cases of primary or secondary DI, including olanzapine (41,89,96,101,141,167,172,199,211,212,249,280), sertindole (348), quetiapine (19,37,76,155,218,249,341), amisulpride (99, 175-177, 212, 253), ziprasidone (99), aripiprazole (141,…”
Section: Atypical Antipsychoticsmentioning
confidence: 99%
“…Also, DP (Freudenreich et al, 2010;Scheinfeld, 2003) and other forms of somatic delusions (Sewell et al, 1994;Torruella et al, 1999) have been noted in individuals with HIV. However, DP has not been documented as a presenting feature in subcortical dementias such as HAD.…”
Section: Introductionmentioning
confidence: 95%
“…In fact, DP (Freudenreich, Kontos, Tranulis, & Cather, 2010;Scheinfeld, 2003) has been documented in HIV-seropositive patients. However, no reports to date have documented DP as a presenting feature of HIV dementia.…”
Section: Introductionmentioning
confidence: 97%